091990 — Celltrion Healthcare Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge Cap

Market Cap
KR₩12tn
Enterprise Value
KR₩12tn
Revenue
KR₩2tn

Annual income statement for Celltrion Healthcare Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS/A	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	695,082	1,100,878	1,627,597	1,804,486	1,972,188
Cost of Revenue
Gross Profit	51,494	209,304	541,775	430,502	561,754
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	737,663	1,018,445	1,265,485	1,625,580	1,743,301
Operating Profit	-42,581	82,433	362,112	178,906	228,887
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	28,880	75,362	314,680	198,257	229,573
Provision for Income Taxes
Net Income After Taxes	14,775	64,962	240,407	152,567	147,179
Minority Interest
Net Income Before Extraordinary Items
Net Income	14,775	64,962	240,407	152,567	147,178
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	14,775	64,962	240,407	152,567	147,178
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	22.5	422	1,505	1,052	950
Dividends per Share